Cell proliferation assays are essential in developmental biology, drug safety research, and cancer therapeutic. More than 10.000 manuscripts in PubMed talk about the sustained signaling pathways ...

Assays to assess the proliferative activity of cells grown in culture or harvested from tissue samples are a core tool for monitoring the health and growth rate of a cell population.

Signal 2 initiates T cell proliferation, the biological process during which T cells multiply to expand the arsenal of immune cells that recognize the antigen and kill cancer cells. Next, the immune ...

Cell Proliferation Assays Suppliers of Cell Proliferation Assays Courtesy of Zymed LaboratoriesMouse anti-PCNA (PC10)-stained colonic mucosa. Scientists often require rapid and accurate measurement of ...

The cell NAD+/NADH ratio can constrain biomass synthesis and influence proliferation in nutrient-limited environments. However, which cell processes regulate the NAD+/NADH ratio is not known. Here, we ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Investigating how mutations in tumors alter DNA’s 3D structure—and subsequently, regulatory sequences called enhancers—can ...

Disruptions in this pathway can promote cancer cell proliferation by increasing cytosolic ... Mass spectrometry and co-immunoprecipitation assays identified interactions between ALDH4A1 and ...

To assess which immune cells harbored CHIP mutations in TI-CH, we performed single-cell genotyping 29 on the tumor immune infiltrate from two TRACERx patients with TI-CH who were not part of the ...

Biovica International receives European patent for its assay, DiviTum TKa to determine prognosis of cancer: Uppsala, Sweden Monday, June 30, 2025, 13:30 Hrs [IST] Biovica Internat ...

For roughly 400 years, microscopes have allowed us to observe increasingly smaller details. Today's most advanced instruments can peer deep into living cells, helping researchers study diseases such ...

Version 2 of the TruSight Oncology 500 research-use-only assay is currently under ... among people with RET fusion-positive non-small cell lung cancer—the latter being a new addition over ...